TILOS THERAPEUTICS
Tilos Therapeutics is developing antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company's initial work is on antibodies specific for Latency Associated Peptide of TGF beta. Tilos was founded in 2016 and is based in Cambridge, Massachusetts.
TILOS THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.tilostherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
508-233-3923
Email Addresses:
[email protected]
Total Funding:
3.8 M USD
Technology used in webpage:
Domain Not Resolving
Founder
Official Site Inspections
http://www.tilostherapeutics.com
Unable to get host informations!!!
Loading ... 